Generation of BT-Amide, a Bone-Targeted Pyk2 Inhibitor, Effective via Oral Administration, for the Prevention of Glucocorticoid-Induced Bone Loss.

Autor: Wang, Xiuqi, Sato, Amy Y., Marino, Silvia, Akel, Nisreen, Boysen, Gunnar, Basnakian, Alexei G., Bellido, Teresita M., Li, Hong-Yu
Zdroj: Journal of Medicinal Chemistry; 11/28/2024, Vol. 67 Issue 22, p20708-20720, 13p
Databáze: Supplemental Index